000 01052 a2200301 4500
005 20250511181932.0
264 0 _c19920602
008 199206s 0 0 eng d
022 _a0002-9173
040 _aNLM
_beng
_cNLM
100 1 _aBrunt, E M
245 0 0 _aImmunoreactivity for c-erbB-2 oncopeptide in benign and malignant diseases of the liver.
_h[electronic resource]
260 _bAmerican journal of clinical pathology
_cMay 1992
300 _aS53-61 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenoma, Bile Duct
_xmetabolism
650 0 4 _aBiomarkers, Tumor
650 0 4 _aCarcinoma, Hepatocellular
_xmetabolism
650 0 4 _aHumans
650 0 4 _aLiver Diseases
_xmetabolism
650 0 4 _aLiver Neoplasms
_xmetabolism
650 0 4 _aProto-Oncogene Proteins
_xmetabolism
650 0 4 _aReceptor, ErbB-2
650 0 4 _aRetrospective Studies
650 0 4 _aStaining and Labeling
700 1 _aSwanson, P E
773 0 _tAmerican journal of clinical pathology
_gvol. 97
_gno. 5 Suppl 1
_gp. S53-61
999 _c1380713
_d1380713